BMI is a leading edge, privately-held biomedical company located in Frederick, Maryland, USA. Founded in 1996 on the proprietary core Immune Refocusing Technology (IRT) the company has stayed at the forefront of industry expansion through the incorporation of the latest computational and engineering advancements. Today the ‘ultra’ (UVC irradiation) vaccine platform and FAST chip diagnostics vanguard our healthcare efforts for underrepresented targets. Throughout the last decade these targets are no longer limited to viral pathogens, but now extend in to bacterial and parasitic prophylactics.
